$4.98
0.326.87%
At close: -
$5.16
0.183.61%
After Hours: Dec 20, 7:48 PM EDT
Comments
Loading...
Vivos Therapeutics (VVOS) Forecast
NewsEarningsVivos Therapeutics (VVOS) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestVivos Therapeutics (NASDAQ:VVOS) Stock Quotes, Forecast and News Summary
Vivos Therapeutics Stock (NASDAQ: VVOS) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Vivos Therapeutics (VVOS) stock?
You can purchase shares of Vivos Therapeutics (NASDAQ:VVOS) through any online brokerage.
Who are Vivos Therapeutics (VVOS) competitors?
Other companies in Vivos Therapeutics’s space includes: Prenetics Global (NASDAQ:PRE), Precipio (NASDAQ:PRPO), Kindly MD (NASDAQ:KDLY), Performant Healthcare (NASDAQ:PHLT) and American Shared Hospital (AMEX:AMS).
What is the forecast, or price target, for Vivos Therapeutics (VVOS) stock?
Vivos Therapeutics has a consensus price target of $5.03.
What is the current price for Vivos Therapeutics (VVOS)?
The stock price for Vivos Therapeutics (NASDAQ: VVOS) is $5.16 last updated December 20, 2024 at 7:48 PM EST.
Does Vivos Therapeutics (VVOS) pay a dividend?
There are no upcoming dividends for Vivos Therapeutics.
When is Vivos Therapeutics (NASDAQ:VVOS) reporting earnings?
Vivos Therapeutics’s Q3 earnings are confirmed for Thursday, November 14, 2024.
Is Vivos Therapeutics (VVOS) going to split?
There is no upcoming split for Vivos Therapeutics.
What sector and industry does Vivos Therapeutics (VVOS) operate in?
Vivos Therapeutics is in the Health Care sector and Health Care Providers & Services industry. They are listed on the NASDAQ.